Transdermal Drug Delivery System-Global Market Status and Trend Report 2013-2023

January 2018 | 152 pages | ID: TC6B2FD2D37EN
MIReports Co., Limited

Abstracts

Report Summary

Transdermal Drug Delivery System-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Transdermal Drug Delivery System industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Regional Market Size of Transdermal Drug Delivery System 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Transdermal Drug Delivery System worldwide, with company and product introduction, position in the Transdermal Drug Delivery System market
Market status and development trend of Transdermal Drug Delivery System by types and applications
Cost and profit status of Transdermal Drug Delivery System, and marketing status
Market growth drivers and challenges

The report segments the global Transdermal Drug Delivery System market as:

Global Transdermal Drug Delivery System Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

North America
Europe
China
Japan
Rest APAC
Latin America

Global Transdermal Drug Delivery System Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other

Global Transdermal Drug Delivery System Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

OTC
Rx

Global Transdermal Drug Delivery System Market: Manufacturers Segment Analysis (Company and Product introduction, Transdermal Drug Delivery System Sales Volume, Revenue, Price and Gross Margin):

Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)

Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier


In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Contents

CHAPTER 1 OVERVIEW OF TRANSDERMAL DRUG DELIVERY SYSTEM

1.1 Definition of Transdermal Drug Delivery System in This Report
1.2 Commercial Types of Transdermal Drug Delivery System
  1.2.1 Fentanyl
  1.2.2 Nitroglycerin
  1.2.3 Estradiol
  1.2.4 Nicotine
  1.2.5 Other
1.3 Downstream Application of Transdermal Drug Delivery System
  1.3.1 OTC
  1.3.2 Rx
1.4 Development History of Transdermal Drug Delivery System
1.5 Market Status and Trend of Transdermal Drug Delivery System 2013-2023
  1.5.1 Global Transdermal Drug Delivery System Market Status and Trend 2013-2023
  1.5.2 Regional Transdermal Drug Delivery System Market Status and Trend 2013-2023

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of Transdermal Drug Delivery System 2013-2017
2.2 Production Market of Transdermal Drug Delivery System by Regions
  2.2.1 Production Volume of Transdermal Drug Delivery System by Regions
  2.2.2 Production Value of Transdermal Drug Delivery System by Regions
2.3 Demand Market of Transdermal Drug Delivery System by Regions
2.4 Production and Demand Status of Transdermal Drug Delivery System by Regions
  2.4.1 Production and Demand Status of Transdermal Drug Delivery System by Regions 2013-2017
  2.4.2 Import and Export Status of Transdermal Drug Delivery System by Regions 2013-2017

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Production Volume of Transdermal Drug Delivery System by Types
3.2 Production Value of Transdermal Drug Delivery System by Types
3.3 Market Forecast of Transdermal Drug Delivery System by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Transdermal Drug Delivery System by Downstream Industry
4.2 Market Forecast of Transdermal Drug Delivery System by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF TRANSDERMAL DRUG DELIVERY SYSTEM

5.1 Global Economy Situation and Trend Overview
5.2 Transdermal Drug Delivery System Downstream Industry Situation and Trend Overview

CHAPTER 6 TRANSDERMAL DRUG DELIVERY SYSTEM MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

6.1 Production Volume of Transdermal Drug Delivery System by Major Manufacturers
6.2 Production Value of Transdermal Drug Delivery System by Major Manufacturers
6.3 Basic Information of Transdermal Drug Delivery System by Major Manufacturers
  6.3.1 Headquarters Location and Established Time of Transdermal Drug Delivery System Major Manufacturer
  6.3.2 Employees and Revenue Level of Transdermal Drug Delivery System Major Manufacturer
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 TRANSDERMAL DRUG DELIVERY SYSTEM MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Hisamitsu
  7.1.1 Company profile
  7.1.2 Representative Transdermal Drug Delivery System Product
  7.1.3 Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin of Hisamitsu
7.2 Mylan
  7.2.1 Company profile
  7.2.2 Representative Transdermal Drug Delivery System Product
  7.2.3 Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin of Mylan
7.3 GSK
  7.3.1 Company profile
  7.3.2 Representative Transdermal Drug Delivery System Product
  7.3.3 Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin of GSK
7.4 Novartis
  7.4.1 Company profile
  7.4.2 Representative Transdermal Drug Delivery System Product
  7.4.3 Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin of Novartis
7.5 Teve (Actavis)
  7.5.1 Company profile
  7.5.2 Representative Transdermal Drug Delivery System Product
  7.5.3 Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin of Teve (Actavis)
7.6 Johnson & Johnson
  7.6.1 Company profile
  7.6.2 Representative Transdermal Drug Delivery System Product
  7.6.3 Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.7 Lohmann
  7.7.1 Company profile
  7.7.2 Representative Transdermal Drug Delivery System Product
  7.7.3 Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin of Lohmann
7.8 Teikoku Seiyaku
  7.8.1 Company profile
  7.8.2 Representative Transdermal Drug Delivery System Product
  7.8.3 Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin of Teikoku Seiyaku
7.9 Bayer
  7.9.1 Company profile
  7.9.2 Representative Transdermal Drug Delivery System Product
  7.9.3 Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin of Bayer
7.10 Lingrui
  7.10.1 Company profile
  7.10.2 Representative Transdermal Drug Delivery System Product
  7.10.3 Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin of Lingrui
7.11 Sanofi
  7.11.1 Company profile
  7.11.2 Representative Transdermal Drug Delivery System Product
  7.11.3 Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin of Sanofi
7.12 Qizheng
  7.12.1 Company profile
  7.12.2 Representative Transdermal Drug Delivery System Product
  7.12.3 Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin of Qizheng
7.13 Endo
  7.13.1 Company profile
  7.13.2 Representative Transdermal Drug Delivery System Product
  7.13.3 Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin of Endo
7.14 Huarun
  7.14.1 Company profile
  7.14.2 Representative Transdermal Drug Delivery System Product
  7.14.3 Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin of Huarun
7.15 Haw Par
  7.15.1 Company profile
  7.15.2 Representative Transdermal Drug Delivery System Product
  7.15.3 Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin of Haw Par
7.16 Nichiban
7.17 Mentholatum Company
7.18 Laboratoires Genevrier
7.19

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF TRANSDERMAL DRUG DELIVERY SYSTEM

8.1 Industry Chain of Transdermal Drug Delivery System
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF TRANSDERMAL DRUG DELIVERY SYSTEM

9.1 Cost Structure Analysis of Transdermal Drug Delivery System
9.2 Raw Materials Cost Analysis of Transdermal Drug Delivery System
9.3 Labor Cost Analysis of Transdermal Drug Delivery System
9.4 Manufacturing Expenses Analysis of Transdermal Drug Delivery System

CHAPTER 10 MARKETING STATUS ANALYSIS OF TRANSDERMAL DRUG DELIVERY SYSTEM

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference